Hookipa Biotech Gmbh

Elizabeth Watson

Thomas P Monath

Katherine Cohen

Klaus Orlinger

Gerhard Fuhrmann

Andreas Aspöck

Bettina Kiefmann

Farshad Guirakhoo

Karen Lingnau

Michael Schwendinger

Sarah Schmidt

Anders Lilja

Vera Baumgartl-Strasser

Mario Aistleithner

Katharina Bayer

Ursula Berka

Elsa Mühlbacher

Manuela Kainer

Julia Hinteramskogler

Bernhard Brim

Andreas ASPÖCK

Elsa MÜHLBACHER

Provided herein are genetically modified arenaviral vectors suitable as vaccines for prevention and treatment of cytomegalovirus infections and reactivation. Also provided herein are pharmaceutical compositions and methods for the treatment of cytomegalovirus infections and reactivation. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of treating cytomegalovirus infections and reactivation.

CMV vaccines

Provided herein are genetically modified arenaviruses suitable as vaccines against neoplastic diseases or cancer. The invention also relates to pharmaceutical compositions and methods for the prevention or treatment of certain infections causing neoplastic diseases or cancer, such as infections with oncogenic viruses. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of preventing or treating diseases and conditions caused by and associated with infections with Human Papillomavirus (HPV), such as cervical cancer, anogenital cancer, head and neck cancer and skin cancers. Also provided herein are immunotherapies for the treatment of a neoplastic disease, such as a neoplastic disease caused by infection with oncogenic viruses.

HPV vaccines

Growing community of inventors

Vienna, Austria

Elizabeth Watson